Veterans' Support Regulations 2014
Veterans' Support Regulations 2014
Veterans' Support Regulations 2014
Version as at 23 October 2025

Veterans’ Support Regulations 2014
(LI 2014/369)
Jerry Mateparae, Governor-General
Order in Council
At Wellington this 1st day of December 2014
Present:
The Right Hon John Key presiding in Council
Note
The Parliamentary Counsel Office has made editorial and format changes to this version using the powers under subpart 2 of Part 3 of the Legislation Act 2019.
Note 4 at the end of this version provides a list of the amendments included in it.
These regulations are administered by the New Zealand Defence Force.
Pursuant to sections 7, 20, 21, 22, 31, 47, 56, 66, 72, 76, 81, 145, 148, 151, 153, 154, 169, 174, 229, 247, 254, 265, 266, and 269 of the Veterans’ Support Act 2014, His Excellency the Governor-General makes the following regulations, acting—
(a)
on the advice and with the consent of the Executive Council; and
(b)
in relation to regulations 9 to 15 and 17, on the recommendation of the Minister of Veterans’ Affairs given in accordance with sections 20, 21, 22, and 269 of that Act.
Contents
Regulations
1 Title
These regulations are the Veterans’ Support Regulations 2014.
2 Commencement
These regulations come into force on 7 December 2014.
3 Interpretation
(1)
In these regulations, unless the context otherwise requires,—
Act means the Veterans’ Support Act 2014
public transport means scheduled public transport (for example, by ferry, bus, or train) but excludes air transport.
(2)
In these regulations, unless the context otherwise requires,—
(a)
terms used but not defined in these regulations and used or defined in the Act have the same meanings as in the Act:
(b)
the amount of any rate or other payment is the amount before the deduction of tax (if any).
Regulation 3: replaced, on 7 December 2015, by regulation 4 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Part 1 Regulations relating to Part 1 of Act
Treatment providers
4 Additional occupational groups to be treatment providers
Regulations 5 to 8 provide that members of certain occupational groups who meet specified criteria are treatment providers for the purposes of the definition of treatment provider in section 7 of the Act.
5 Acupuncturists
A person who is an acupuncturist is a treatment provider if the person—
(a)
is registered as a practitioner of acupuncture with the Chinese Medicine Council of New Zealand, established by the Health Practitioners Competence Assurance (Designation of Chinese Medicine Services as Health Profession) Order 2021; and
(b)
holds a current practising certificate.
Regulation 5: replaced, on 4 September 2025, by regulation 4 of the Veterans’ Support (Treatment Providers) Amendment Regulations 2025 (SL 2025/169).
6 Audiologists
A person who is an audiologist is a treatment provider if the person—
(a)
is a full audiologist member of the New Zealand Audiological Society Incorporated; and
(aa)
holds a current practising certificate; and
(b)
when acting as an audiologist, is not acting—
(i)
in the course of employment by a supplier of hearing aids; or
(ii)
as a supplier of hearing aids.
Regulation 6(a): amended, on 4 September 2025, by regulation 5(1) of the Veterans’ Support (Treatment Providers) Amendment Regulations 2025 (SL 2025/169).
Regulation 6(aa): inserted, on 4 September 2025, by regulation 5(2) of the Veterans’ Support (Treatment Providers) Amendment Regulations 2025 (SL 2025/169).
Regulation 6(b)(i): amended, on 4 September 2025, by regulation 5(3) of the Veterans’ Support (Treatment Providers) Amendment Regulations 2025 (SL 2025/169).
6A Audiometrists
A person who is an audiometrist is a treatment provider if the person—
(a)
is a full audiometrist member of the New Zealand Audiological Society Incorporated; and
(b)
holds a current practising certificate; and
(c)
when acting as an audiometrist, is not acting—
(i)
in the course of employment by a supplier of hearing aids; or
(ii)
as a supplier of hearing aids.
Regulation 6A: inserted, on 4 September 2025, by regulation 6 of the Veterans’ Support (Treatment Providers) Amendment Regulations 2025 (SL 2025/169).
6B Chinese medicine practitioners
A person who is a Chinese medicine practitioner is a treatment provider if the person—
(a)
is registered as a practitioner of Chinese medicine services with the Chinese Medicine Council of New Zealand, established by the Health Practitioners Competence Assurance (Designation of Chinese Medicine Services as Health Profession) Order 2021; and
(b)
holds a current practising certificate.
Regulation 6B: inserted, on 4 September 2025, by regulation 6 of the Veterans’ Support (Treatment Providers) Amendment Regulations 2025 (SL 2025/169).
7 Counsellors
A person who is a counsellor is a treatment provider if the person is—
(a)
a health practitioner under the Health Practitioners Competence Assurance Act 2003 and counselling is within his or her scope of practice under that Act; or
(b)
recognised by the Accident Compensation Corporation as a counsellor for the purposes of the Accident Compensation Act 2001.
7A Paramedics
A person who is a paramedic is a treatment provider if the person—
(a)
is registered as a paramedic with the Paramedic Council, established by the Health Practitioners Competence Assurance (Designation of Paramedic Services as Health Profession) Order 2019; and
(b)
holds a current practising certificate.
Regulation 7A: inserted, on 4 September 2025, by regulation 7 of the Veterans’ Support (Treatment Providers) Amendment Regulations 2025 (SL 2025/169).
8 Speech therapists
A person who is a speech therapist is a treatment provider if the person is a member of the New Zealand Speech-Language Therapists’ Association Incorporated.
Paired organs
9 Paired organs
The following organs are paired organs for the purposes of section 20 of the Act:
(a)
adrenal glands:
(b)
breasts:
(c)
ears:
(d)
eyes:
(e)
kidneys:
(f)
lungs:
(g)
ovaries:
(h)
testicles.
Illnesses and conditions conclusively presumed to be service-related
10 Conclusively presumed illnesses and conditions
Regulations 11 to 14 provide that certain illnesses and conditions in relation to certain events or deployments are to be treated as service-related for the purpose of section 21 of the Act.
11 World War II prisoners of war
(1)
This regulation applies to a veteran if the veteran was a prisoner of war at any time during World War II.
(2)
If the veteran suffers from an illness or a condition described in subclause (3), the illness or condition must be treated as service-related.
(3)
The illnesses and conditions are—
(a)
any of the anxiety states:
(b)
beriberi:
(c)
chronic dysentery:
(d)
cirrhosis of the liver:
(e)
dysthymia:
(f)
heart disease or hypertensive vascular disease, including complications:
(g)
helminthiasis (intestinal vermiform parasites):
(h)
hypovitaminosis:
(i)
irritable bowel syndrome:
(j)
malnutrition (including optic atrophy):
(k)
organic residuals of frostbite:
(l)
peptic ulcer disease:
(m)
pellagra and any other nutritional deficiencies:
(n)
peripheral neuropathy:
(o)
post-traumatic osteoarthritis:
(p)
psychosis:
(q)
stroke and residuals of stroke.
12 Exposure to nuclear radiation
(1)
This regulation applies to a veteran if the veteran served—
(a)
with J Force in Japan at any time during the years 1946 to 1952; or
(b)
on HMNZS Pukaki or HMNZS Rotoiti at any time during the years 1957 and 1958; or
(c)
on HMNZS Otago on 22 July 1973; or
(d)
on HMNZS Canterbury on 28 July 1973.
(2)
If the veteran suffers from an illness or a condition described in subclause (3), the illness or condition must be treated as service-related.
(3)
The illnesses and conditions are—
(a)
all forms of leukaemia (except for chronic lymphocytic leukaemia):
(b)
bronchioloalveolar carcinoma:
(c)
cancer of the thyroid, breast, pharynx, oesophagus, stomach, small intestine, pancreas, bile ducts, gall bladder, salivary gland, urinary tract (renal, ureter, urinary bladder, or urethra), brain, bone, lung, colon, or ovary:
(d)
lymphomas (other than Hodgkin’s disease):
(e)
multiple myeloma:
(f)
primary liver cancer (except if cirrhosis or hepatitis B is indicated).
13 Vietnam
(1)
This regulation applies to a veteran if the veteran served in Vietnam—
(a)
at any time during the period beginning on 29 May 1964 and ending on the close of 31 December 1972; or
(b)
with 41 Squadron RNZAF at any time during the period beginning on 1 January 1973 and ending on the close of 21 April 1975; or
(c)
as a member of the civilian surgical team at Qui Nhon Provincial State Hospital, Binh Dinh province at any time during the period beginning on 1 December 1963 and ending on the close of 31 March 1975.
(2)
If the veteran suffers from an illness or a condition described in subclause (3), the illness or condition must be treated as service-related.
(3)
The illnesses and conditions are—
(a)
acute and subacute peripheral neuropathy:
(b)
AL-type primary amyloidosis:
(c)
chloracne:
(d)
chronic lymphocytic leukaemia (including hairy-cell leukaemia and any other chronic B-cell leukaemias):
(e)
Hodgkin’s disease:
(f)
hypertension:
(g)
ischaemic heart disease:
(h)
multiple myeloma:
(i)
non-Hodgkin’s lymphoma:
(j)
Parkinson’s disease:
(k)
porphyria cutanea tarda:
(l)
prostate cancer:
(m)
respiratory cancers (lung, bronchus, larynx, and trachea):
(n)
soft tissue sarcoma:
(o)
stroke:
(p)
type 2 diabetes.
14 Gulf War
(1)
This regulation applies to a veteran if the veteran served in the Gulf War at any time during the period beginning on 20 December 1990 and ending on the close of 13 April 1991.
(2)
If the veteran suffers from an illness or a condition in subclause (3), the illness or condition must be treated as service-related.
(3)
The illnesses and conditions are—
(a)
medically unexplained chronic multi-symptom illnesses—
(i)
that are defined by a cluster of signs or symptoms, such as—
(A)
chronic fatigue syndrome:
(B)
fibromyalgia:
(C)
irritable bowel syndrome; and
(ii)
that have existed for 6 months or more:
(b)
signs or symptoms of an undiagnosed illness that include fatigue, skin symptoms, headaches, muscle pain, joint pain, neurological symptoms, respiratory symptoms, sleep disturbance, gastro-intestinal symptoms, cardiovascular symptoms, weight loss, or menstrual disorders.
Statements of principles
15 Certain Australian statements of principles apply
(1)
The statements of principles described in Schedule 1 apply for the purposes of the Act.
(2)
The version of a statement of principles referred to in Schedule 1 in the column headed “Reasonable hypothesis”
is to be applied if a veteran’s service-related injury, illness, condition, whole-person impairment, or death relates to qualifying operational service.
(3)
The version of a statement of principles referred to in Schedule 1 in the column headed “Balance of probabilities”
is to be applied if a veteran’s service-related injury, illness, condition, whole-person impairment, or death relates to qualifying routine service.
Indexation under section 30 of Act
Heading: inserted, on 7 December 2015, by regulation 5 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
15A Formula for indexation under section 30 of Act
(1)
This regulation sets out the formula for the indexation of the amounts described in section 30(1) of the Act.
(2)
The formula is as follows:
a × (b ÷ c)
where—
- a
is the amount at the date of indexation, before the amount is adjusted
- b
is the LCI figure for the March quarter immediately prior to the date of indexation
- c
is the LCI figure for the March quarter prior to the quarter referred to in item b.
(3)
In subclause (2), LCI means the Labour Cost Index All Salary and Wage Rates (including overtime), all industries and sectors combined published by Statistics New Zealand or, if that index ceases to be published, any measure certified by the Government Statistician as being equivalent to that index.
(4)
For the purposes of applying the formula in subclause (2),—
(a)
the number resulting from dividing item b by item c must be rounded up or down to 4 decimal places (with 0.00005 or greater being rounded up):
(b)
the result must be rounded to the nearest cent as follows:
(i)
an amount of less than 0.5 cents must be rounded down:
(ii)
an amount of 0.5 cents or more than 0.5 cents must be rounded up.
(5)
An amount that is adjusted by applying the formula takes effect on and from 1 July after the March quarter referred to in item b in subclause (2).
(6)
However, no amount is to be adjusted if the application of the formula produces a negative figure.
Regulation 15A: inserted, on 7 December 2015, by regulation 5 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Regulation 15A(3): replaced, on 1 September 2022, by section 107(1) of the Data and Statistics Act 2022 (2022 No 39).
Indexation under section 31 of Act
Heading: replaced, on 7 December 2015, by regulation 6 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
16 Formula for indexation of certain entitlements under section 31 of Act
(1)
This regulation sets out the formula for the indexation of the following entitlements under section 31 of the Act:
(a)
the rates of disablement pension (section 56 of the Act):
(b)
the rate of the surviving spouse or partner pension (section 66 of the Act):
(c)
the rate of the children’s pension (section 72 of the Act):
(d)
the rate of the dependant’s pension (section 76 of the Act):
(e)
the rate of the children’s bursary (section 81 of the Act):
(f)
the maximum amount for motor vehicle grants (section 148 of the Act):
(g)
the amount of the retirement lump sum payment (section 151 of the Act):
(h)
the asset threshold for non-exempt assets (section 151 of the Act):
(i)
the maximum amount payable for funeral expenses for a veteran whose death is attributable to qualifying service (section 153 of the Act):
(j)
the maximum amount payable for funeral expenses for a veteran whose death is not attributable to qualifying service (section 154 of the Act):
(k)
the lump sum payment to a surviving spouse or partner of a veteran receiving the veteran’s pension (section 174 of the Act).
(2)
The formula is as follows:
a × (b ÷ c)
where—
- a
is the amount of the entitlement at the date of indexation, before the amount is adjusted
- b
is the CPI figure for the December quarter immediately prior to the date of indexation
- c
is the CPI figure for the December quarter prior to the quarter referred to in item b.
(3)
In subclause (2), CPI means the Consumers Price Index (all groups) published by Statistics New Zealand or, if that index ceases to be published, any measure certified by the Government Statistician as being equivalent to that index.
(4)
For the purposes of applying the formula in subclause (2),—
(a)
the number resulting from dividing item b by item c must be rounded up or down to 4 decimal places (with 0.00005 or greater being rounded up):
(b)
the result must be rounded to the nearest cent as follows:
(i)
an amount of less than 0.5 cents must be rounded down:
(ii)
an amount of 0.5 cents or more than 0.5 cents must be rounded up.
(5)
An entitlement that is adjusted by applying the formula takes effect on and from 1 April after the December quarter referred to in item b in subclause (2).
(6)
However, no entitlement is to be adjusted if the application of the formula produces a negative figure.
Regulation 16(1): replaced, on 7 December 2015, by regulation 7(1) of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Regulation 16(2) formula: replaced, on 7 December 2015, by regulation 7(2) of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Regulation 16(3): replaced, on 1 September 2022, by section 107(1) of the Data and Statistics Act 2022 (2022 No 39).
16A Formula for indexation of lump sum for permanent impairment, survivor’s grant, and child care payments
(1)
This regulation sets out the formula for the indexation of the following entitlements under section 31 of the Act:
(a)
the lump sum payment for permanent impairment (section 98 of the Act):
(b)
the survivor’s grant (clause 53 of Schedule 2 of the Act):
(c)
child care payments for children of deceased veterans (clause 64 of Schedule 2 of the Act).
(2)
The formula is as follows:
a × (b ÷ c)
where—
- a
is the amount of the entitlement at the date of indexation, before the amount is adjusted
- b
is the CPI figure for the March quarter immediately prior to the date of indexation
- c
is the CPI figure for the March quarter prior to the quarter referred to in item b.
(3)
In subclause (2), CPI means the Consumers Price Index (all groups) published by Statistics New Zealand or, if that index ceases to be published, any measure certified by the Government Statistician as being equivalent to that index.
(4)
For the purposes of applying the formula in subclause (2),—
(a)
the number resulting from dividing item b by item c must be rounded up or down to 4 decimal places (with 0.00005 or greater being rounded up):
(b)
the result must be rounded to the nearest cent as follows:
(i)
an amount of less than 0.5 cents must be rounded down:
(ii)
an amount of 0.5 cents or more than 0.5 cents must be rounded up.
(5)
An entitlement that is adjusted by applying the formula takes effect on and from 1 July after the March quarter referred to in item b in subclause (2).
(6)
However, no entitlement is to be adjusted if the application of the formula produces a negative figure.
Regulation 16A: inserted, on 7 December 2015, by regulation 8 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Regulation 16A(3): replaced, on 1 September 2022, by section 107(1) of the Data and Statistics Act 2022 (2022 No 39).
Part 2 Regulations relating to Part 3 of Act
Rate of disablement pension
17 Rate of disablement pension
(1)
The rate of a veteran’s disablement pension payable under section 56 of the Act is to be determined according to the level of the veteran’s whole-person impairment.
(2)
The rates of the disablement pension are set out in Schedule 2.
(3)
A veteran’s level of whole-person impairment in the first column of Schedule 2 is to be determined in accordance with the American Medical Association Guides to the Evaluation of Permanent Impairment (4th ed).
(4)
To avoid doubt, the level of whole-person impairment of a veteran who is applying for a disablement pension under clause 6(2) of Schedule 1 of the Act is to be assessed in accordance with the American Medical Association Guides to the Evaluation of Permanent Impairment (4th ed).
Surviving spouse or partner pension
18 Rate of surviving spouse or partner pension
The rate of the surviving spouse or partner pension payable under section 66 of the Act is $160.04 per week.
Children’s pension
19 Rate of children’s pension
The rate of the children’s pension payable under section 72 of the Act is $171.38 per week.
Dependant’s pension
20 Maximum rate of dependant’s pension
The maximum rate of a dependant’s pension payable under section 76 of the Act is $160.04 per week.
21 VANZ to take into account dependant’s economic position in determining actual rate
(1)
Regulations 22 to 25 specify the criteria that VANZ must take into account in assessing a dependant’s economic position for the purpose of determining the rate of a dependant’s pension payable to the dependant.
(2)
If, at any time, VANZ has reason to believe that a dependant’s economic position has changed, VANZ may reassess the dependant’s economic position in order to determine the appropriate rate payable to the dependant.
22 Rate of dependant’s pension
(1)
If a dependant’s weekly income is equal to or less than 50% of the maximum rate, the pension payable to the dependant is the maximum rate.
(2)
If a dependant’s weekly income is more than 50% of the maximum rate, the pension payable to the dependant is the maximum rate minus $1 for every $1 of income that exceeds 50% of the maximum rate.
(3)
For the purposes of this regulation, a dependant’s weekly income is the amount equivalent to the dependant’s income (inclusive of any income tax) during the preceding 12-month period divided by 52.
23 Dependant’s income
(1)
For the purposes of regulation 22(3), a dependant’s income includes—
(a)
income received by the dependant:
(b)
income received by the dependant’s spouse or partner:
(c)
any benefits paid to the dependant under the Social Security Act 2018:
(d)
income derived from assets owned by the dependant:
(e)
income derived from assets owned by the dependant’s spouse or partner.
(2)
A dependant’s income does not include—
(a)
any assets received by the dependent, or the dependant’s spouse or partner, that are defined as exempt assets, exempted from a means assessment, or declared not to be cash assets under a social security enactment:
(b)
any income derived from assets of the type described in paragraph (a):
(c)
any income that is exempted from a means assessment or declared not to be income under a social security enactment:
(d)
the dependant’s interest in a residential dwelling that is the dependant’s principal residence:
(e)
the dependant’s interest in a car or similar vehicle for the dependant’s own use.
(3)
In this regulation, unless the context otherwise requires,—
income has the meaning given by Schedule 2 of the Social Security Act 2018
social security enactment means—
(a)
Schedule 2 of the Residential Care and Disability Support Services Act 2018:
(b)
the Social Security (Long-term Residential Care) Regulations 2005 (or any other regulations made or treated as made under section 74 of the Residential Care and Disability Support Services Act 2018):
(c)
the Social Security (Income and Cash Assets Exemptions) Regulations 2011 (or any other regulations made or treated as made—
(i)
under section 422 for the purposes of clause 9 of Schedule 3 of the Social Security Act 2018; or
(ii)
under section 423 for the purposes of subpart 10 of Part 2 and Part 7 of Schedule 4 of the Social Security Act 2018):
(d)
the Social Security (Temporary Additional Support) Regulations 2005 (or any other regulations made or treated as made under section 428 of the Social Security Act 2018).
(4)
For the purposes of this regulation, any reference in an enactment referred to in subclause (3) to the chief executive is to be read as a reference to VANZ.
Regulation 23(1)(c): amended, on 26 November 2018, by section 459 of the Social Security Act 2018 (2018 No 32).
Regulation 23(3) income: amended, on 26 November 2018, by section 459 of the Social Security Act 2018 (2018 No 32).
Regulation 23(3) social security enactment: replaced, on 26 November 2018, by section 459 of the Social Security Act 2018 (2018 No 32).
24 Deprivation of assets and income
(1)
If VANZ is satisfied that a dependant, or the dependant’s spouse or partner, has directly or indirectly deprived himself or herself of any assets or income, VANZ, in assessing the dependant’s economic position, may treat the deprivation as if it had not occurred.
(2)
Subclause (1) does not apply if the deprivation occurred before the veteran for which the pension is payable—
(a)
died; or
25 How value of land to be determined
(1)
If an assessment of a dependant’s economic position involves determining the value of land, the value is to be determined in accordance with regulations 9D and 9E of the Social Security (Long-term Residential Care) Regulations 2005.
(2)
For the purposes of subclause (1), regulations 9D and 9E of those regulations apply with all necessary modifications and as if references to the chief executive were references to VANZ.
Children’s bursaries
26 Rates of children’s bursaries
(1)
This regulation specifies the rates of children’s bursaries payable under section 81 of the Act.
(2)
The children’s bursary payable in respect of a child who, immediately before the commencement of Part 3 of the Act, was receiving a children’s pension under section 40 of the War Pensions Act 1954 or who is the child of a veteran receiving a veteran’s pension is—
(a)
$905.75, if the child is undertaking full-time study at a secondary school:
(b)
$452.82, if the child is undertaking part-time study at a tertiary institution:
(c)
$1,074.78, if the child is undertaking full-time study at a tertiary institution.
(3)
The children’s bursary payable to a child who is not described in subclause (2) is—
(a)
$452.84, if the child is undertaking full-time study at a secondary school:
(b)
$226.41, if the child is undertaking part-time study at a tertiary institution:
(c)
$537.36, if the child is undertaking full-time study at a tertiary institution.
(4)
A children’s bursary is paid annually in the year in which a child is entitled to the bursary.
Part 2A Regulations relating to Part 4 of Act
Part 2A: inserted, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Accepted late-onset conditions
Heading: inserted, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
26A Accepted late-onset conditions
The conditions specified in Schedule 2A are accepted late-onset conditions for the purposes of the definition of accepted late-onset condition in section 7 of the Act.
Regulation 26A: inserted, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Transport costs for treatment
Heading: inserted, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
26B Transport costs associated with treatment
(1)
This regulation specifies the extent to which VANZ is responsible, under section 88(1) of the Act, for paying the costs of transport the veteran reasonably requires in order to receive treatment that VANZ is responsible for paying or contributing to the cost of.
(2)
VANZ must pay the veteran—
(a)
any fares paid for public transport for a journey:
(b)
for a journey in a private vehicle, $0.62 for each kilometre for the first 200 kilometres of the journey:
(c)
if VANZ approves the following costs for a journey before the veteran undertakes the journey:
(i)
the cost of any air fares paid for the journey:
(ii)
any other costs of transport for the journey.
(3)
In subclause (2), journey—
(a)
means a journey from a veteran’s residence to the most appropriate place of treatment (as determined by VANZ) by the most direct route and the return journey from that place (if the veteran makes a return journey); but
(b)
does not include any international part of a journey described in paragraph (a).
(4)
If the veteran is entitled to be paid the costs of transport by the Accident Compensation Corporation (ACC) for a journey and the amount that is payable by VANZ to the veteran under subclause (2) for the journey is greater than the amount the veteran is entitled to be paid by ACC, the amount that VANZ must pay to the veteran is limited to the difference between the costs of transport payable under subclause (2) and the amount payable by ACC.
Regulation 26B: inserted, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Lump sum payment in place of independence allowance
Heading: inserted, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
26C Lump sum payment in place of independence allowance
(1)
This regulation specifies the amount of the lump sum payment that a veteran may elect to receive in place of weekly payments of the independence allowance to which the veteran is entitled under section 96 of the Act.
(2)
The veteran may elect to receive in place of weekly payments, over a period of 52 weeks (the lump sum period), an amount calculated in accordance with the formula in subclause (3).
(3)
The formula is—
a × 51.6075
where a is the weekly rate of independence allowance to which the veteran is entitled at the time of the election to receive a lump sum payment.
(4)
An election to receive a lump sum payment under this regulation must be in writing.
(5)
The lump sum period begins on the date on which the veteran would have received payment of the independence allowance if the veteran had not made the election.
Regulation 26C: inserted, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
26D Additional amount payable if veteran’s whole-person impairment increases
(1)
A veteran who has received a lump sum payment is entitled to an additional amount calculated in accordance with the formula in subclause (2) if, during the lump sum period, the veteran’s whole-person impairment increases with the effect that he or she would have been entitled to a higher weekly rate of independence allowance if he or she had not elected to receive the lump sum payment.
(2)
The formula is—
[2 × (a − b)] × (1 − 1.000562(−0.5 × c)) ÷ 0.000562
where—
- a
is the weekly rate of independence allowance to which the veteran would have been entitled immediately after the increase in the person’s whole-person impairment if he or she had not elected to receive the lump sum payment
- b
is the weekly rate of independence allowance to which the veteran would have been entitled immediately before the increase in the person’s whole-person impairment if he or she had not elected to receive the lump sum payment
- c
is the number of full weeks remaining in the lump sum period.
(3)
To avoid doubt,—
(a)
an increase in whole-person impairment has the effect of increasing the independence allowance payable to a veteran only if the increase is caused by a service-related injury or illness that occurred in the period beginning on 1 April 1974 and ending on the close of 31 March 2002 (see section 96(1) of the Act):
(b)
a veteran is under no obligation to repay VANZ any amount if, during the lump sum period, his or her whole-person impairment decreases.
Regulation 26D: inserted, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Lump sum compensation for permanent impairment
Heading: inserted, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
26E Lump sum compensation for permanent impairment
(1)
The amount of lump sum compensation for permanent impairment payable to a veteran under section 98 and clause 45 of Schedule 2 of the Act must be determined according to the level of the veteran’s whole-person impairment.
(2)
The amounts of lump sum compensation for permanent impairment that are payable for each level of whole-person impairment are set out in Schedule 2B.
(3)
A veteran’s level of whole-person impairment in the first column of Schedule 2B is to be determined in accordance with the American Medical Association Guides to the Evaluation of Permanent Impairment (4th ed).
Regulation 26E: inserted, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Part 3 Regulations relating to Part 5 of Act
Part 3 heading: replaced, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Veterans’ independence programme
Heading: inserted, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
26F Assessment of need
(1)
For the purpose of determining the services and support to be provided to a veteran, VANZ must assess the extent of the veteran’s ability to undertake activities that are required in order for the veteran to live independently in his or her home.
(2)
If VANZ reasonably considers it is necessary in order to make the assessment referred to in subclause (1), VANZ may require the veteran to undergo an assessment in person (at VANZ’s cost).
(3)
VANZ must make the assessment described in subclause (1)—
(a)
on receiving an application from the veteran in accordance with section 142 of the Act:
(b)
if the application is accepted, once in every year after the application is accepted.
(4)
If a person assessing a veteran under subclause (2) reasonably considers that the veteran’s ability to undertake activities that are required in order for the veteran to live independently in his or her home is likely to change within the following year, VANZ may make the assessment described in subclause (1) more frequently than once in every year.
Regulation 26F: inserted, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
26G Services and support provided by others
VANZ is not required to provide to a veteran under the veterans’ independence programme any services or support that the veteran receives from any other person or agency.
Regulation 26G: inserted, on 7 December 2015, by regulation 9 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Weekly battery allowance
27 Entitlement to weekly battery allowance
A veteran is entitled to a weekly battery allowance if the veteran—
(a)
has a service-related hearing loss; and
(b)
is using a hearing aid that is approved by VANZ and that VANZ considers necessary and suitable for the veteran’s service-related hearing loss; and
(c)
is not being—
(i)
supplied with hearing aid batteries from anyone other than VANZ; or
(ii)
provided with funding for hearing aid batteries from anyone other than VANZ.
28 Rate of weekly battery allowance
The rate of the weekly battery allowance for the purposes of section 145(b) of the Act is—
(a)
$1.05, if a hearing aid is required for only 1 ear:
(b)
$2.13, if a hearing aid is required for each ear.
Motor vehicle grants
29 Interpretation
(1)
In regulations 30 and 31,—
severe lower body mobility impairment means a service-related impairment due to—
(a)
amputation of a lower limb; or
(b)
severe and permanent loss of function of the lower extremity affecting mobility
total lower body mobility impairment means a service-related impairment due to—
(a)
paraplegia; or
(b)
amputation of both lower limbs; or
(c)
total or near-total permanent loss of function of the lower extremity affecting mobility.
(2)
For the purposes of subclause (1), lower extremity means that part of the body from both hips (including the pelvis) to the toes of both feet.
30 Maximum amount of grant
The maximum amount of a motor vehicle grant under section 147 of the Act is—
(a)
$8,361.87, in the case of severe lower body mobility impairment:
(b)
$18,580.73, in the case of total lower body mobility impairment.
31 Frequency of grants
(1)
A motor vehicle grant in relation to severe lower body mobility impairment may be made to a veteran only once.
(2)
A motor vehicle grant in relation to total lower body mobility impairment may be made more than once, but only at intervals of not less that 5 years.
32 Additional grant for fitting controls
A veteran who receives a motor vehicle grant may also apply for an additional grant, up to a maximum of $3,000, for the purpose of fitting special driving controls to a vehicle without which the veteran would be unable to drive the vehicle.
33 Criteria for determining whether to make grant
The matters to be taken into account in determining whether to make a grant or an additional grant in relation to a motor vehicle are—
(a)
the nature and extent of a veteran’s lower body impairment; and
(b)
the veteran’s need for a motor vehicle or for the special controls; and
(c)
the suitability of the motor vehicle or the special controls for the veteran’s impairment and needs; and
(d)
the cost and condition of the motor vehicle or the special controls; and
(e)
whether the veteran will be able to drive the vehicle safely; and
(f)
whether the veteran will be legally permitted to drive the motor vehicle in the country in which the veteran intends to operate the vehicle (including whether the veteran holds or will be able to hold a valid driver’s licence); and
(g)
whether the motor vehicle or the special controls will comply with or be exempted from any applicable laws for operation of a motor vehicle in the country in which the veteran intends to operate that vehicle, such as vehicle registration and warrant of fitness; and
(h)
whether the veteran has or is able to obtain comprehensive motor vehicle insurance for the motor vehicle; and
(i)
if the motor vehicle is a mobility scooter or similar vehicle, whether the veteran has a medical certificate that indicates the veteran is capable of operating the vehicle; and
(j)
whether the veteran has received any previous assistance from VANZ, including (but not limited to) a motor vehicle loan under the War Pensions Act 1954, and how long ago that assistance was received; and
(k)
whether the veteran has received any money from the sale of a motor vehicle, or any part of a motor vehicle, that VANZ has previously helped purchase (and, if so, the amount received).
Retirement lump sums
34 Amount of retirement lump sum
The retirement lump sum under section 149 of the Act is $33,000.
35 Asset threshold for non-exempt assets
(1)
This regulation specifies the asset threshold for non-exempt assets for the purposes of section 149 of the Act, being the threshold at or above which a veteran does not qualify for a retirement lump sum under that section.
(2)
The asset threshold for a veteran who does not have a spouse or partner is $500,000, including the value of a residential dwelling and a vehicle.
(3)
A veteran who has a spouse or partner may elect one of the following asset thresholds:
(a)
$300,000, excluding the value of a residential dwelling and a vehicle:
(b)
$500,000, including the value of a residential dwelling and a vehicle.
36 Assets to be included in asset assessment
(1)
Assets to be included in an asset assessment under section 150 of the Act are the assets of the veteran and his or her spouse or partner (if any) that would come within the definition of assets in clause 4 of Schedule 2 of the Residential Care and Disability Support Services Act 2018 (if the veteran were a person being means assessed under section 34 of that Act).
(2)
However, assets that are exempt assets and gifts that are allowable gifts are not included in an asset assessment.
(3)
For the purposes of subclause (2),—
(a)
an asset is an exempt asset if it would be an exempt asset under—
(i)
clause 4 of Schedule 2 of the Residential Care and Disability Support Services Act 2018; or
(ii)
regulation 10 of the Social Security (Long-term Residential Care) Regulations 2005:
(b)
a gift is an allowable gift if the gift would be or would be treated as an allowable gift under regulations 9 and 9A of the Social Security (Long-term Residential Care) Regulations 2005.
Regulation 36(1): amended, on 26 November 2018, by section 459 of the Social Security Act 2018 (2018 No 32).
Regulation 36(3)(a)(i): amended, on 26 November 2018, by section 459 of the Social Security Act 2018 (2018 No 32).
37 Deprivation of assets
(1)
If VANZ is satisfied that a veteran or his or her spouse or partner (if any) has directly or indirectly deprived himself or herself of any assets (other than exempt assets), the veteran’s asset assessment under section 150 of the Act may be conducted as if the deprivation had not occurred.
(2)
For the purposes of subclause (1), instances of deprivation of assets include, but are not limited to, the instances described in regulation 9B(a) to (f) of the Social Security (Long-term Residential Care) Regulations 2005.
38 Gifting period
For the purposes of clauses 36 and 37, a reference to the gifting period in clause 4 of Schedule 2 of the Residential Care and Disability Support Services Act 2018 and in regulations 9 to 9B of the Social Security (Long-term Residential Care) Regulations 2005 is to be read as the period of 5 years immediately preceding the date on which the veteran reached the New Zealand superannuation qualification age.
Regulation 38: amended, on 26 November 2018, by section 459 of the Social Security Act 2018 (2018 No 32).
39 How value of land to be determined
(1)
If an asset assessment under section 150 of the Act involves determining the value of land, the value is to be determined in accordance with regulations 9D and 9E of the Social Security (Long-term Residential Care) Regulations 2005.
(2)
For the purposes of subclause (1), regulations 9D and 9E of those regulations apply with all necessary modifications and as if references to the chief executive were references to VANZ.
Funeral expenses
40 Funeral expenses
For the purposes of sections 153 and 154 of the Act, the maximum amount payable in relation to expenses of a funeral and burial or cremation of a veteran is $2,442.96.
41 Cost of transport of veteran’s body
For the purposes of section 153(5) of the Act, the maximum amount payable for transporting a veteran’s body from the hospital in which he or she died to the place of the veteran’s burial or cremation is—
(a)
$650, if the place is within the locality of the hospital:
(b)
$1,300, if the place is outside the locality of the hospital.
Financial advice
Heading: inserted, on 7 December 2015, by regulation 10 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
41A Prescribed amount for entitlement to costs of financial advice
(1)
This regulation prescribes an amount for the purposes of section 157(1)(b) of the Act.
(2)
The prescribed amount is $15,000.
Regulation 41A: inserted, on 7 December 2015, by regulation 10 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Part 4 Regulations relating to Part 6 of Act
Rates of veteran’s pension
42 Rates of veteran’s pension
(1)
Notices of adjustment of the rates of veteran’s pension payable under Part 6 of the Veterans’ Support Act 2014 are published on an internet site maintained by or on behalf of VANZ in accordance with section 170 of the Veterans’ Support Act 2014.
(2)
The rates payable are subject to any abatement under regulation 42A.
Regulation 42: replaced, on 1 April 2021, by regulation 4 of the Veterans’ Support Amendment Regulations (No 2) 2021 (LI 2021/27).
42A Abatement of veteran’s pension
(1)
The amount payable to a veteran who is entitled to a veteran’s pension under—
(a)
section 161 of the Act is subject to abatement in accordance with subclause (2), if the veteran receives the veteran’s pension at the relationship (partner not receiving superannuation or pension) rate or the relationship (partner not receiving superannuation or pension) legacy rate:
(b)
section 164 of the Act is subject to abatement in accordance with subclause (3), if the veteran receives the veteran’s pension at the relationship rate, the single living alone rate, or the single sharing accommodation rate:
(c)
section 164 of the Act is subject to abatement in accordance with subclause (4), if the veteran receives the veteran’s pension at the relationship (partner not receiving superannuation or pension) rate or the relationship (partner not receiving superannuation or pension) legacy rate.
(2)
On and from 1 April 2021 VANZ must, in calculating the veteran’s pension payable to a veteran to whom this subclause applies, reduce the amount of the pension payable by 70 cents for every $1 of the combined income of the person receiving a veteran’s pension and his or her spouse or partner that exceeds $160 per week.
(3)
On and from 1 April 2021 VANZ must, in calculating the veteran’s pension payable to a veteran to whom this subclause applies, reduce the amount of the pension payable by—
(a)
30 cents for every $1 of the employment income derived by the veteran (before deduction of income tax) that exceeds $160 per week, but does not exceed $250 per week; and
(b)
70 cents for every $1 of the employment income derived by the veteran (before the deduction of income tax) that exceeds $250 per week.
(4)
On and from 1 April 2021 VANZ must, in calculating the veteran’s pension payable to a veteran to whom this subclause applies, reduce the amount of the pension payable by—
(a)
30 cents for every $1 of the combined income derived by the veteran and the veteran’s spouse or partner that exceeds $160 per week, but does not exceed $250 per week; and
(b)
70 cents for every $1 of the combined income derived by the veteran and the veteran’s spouse or partner that exceeds $250 per week.
Regulation 42A: inserted, on 1 April 2020, by regulation 5 of the Veterans’ Support (Abatement) Amendment Regulations 2020 (LI 2020/27).
Regulation 42A(2): replaced, on 1 April 2021, by regulation 5 of the Veterans’ Support Amendment Regulations (No 2) 2021 (LI 2021/27).
Regulation 42A(3): replaced, on 1 April 2021, by regulation 5 of the Veterans’ Support Amendment Regulations (No 2) 2021 (LI 2021/27).
Regulation 42A(4): replaced, on 1 April 2021, by regulation 5 of the Veterans’ Support Amendment Regulations (No 2) 2021 (LI 2021/27).
Lump sum payment on death
43 Lump sum payment on death of veteran
(1)
This regulation specifies the amount payable under section 174(2) of the Act on the death of—
(a)
a veteran to whom section 162(1) of the Act applies and who, on the date of death,—
(i)
is ordinarily resident in New Zealand; and
(ii)
is receiving a veteran’s pension; or
(b)
a veteran who, on the date of death,—
(i)
is ordinarily resident in New Zealand; and
(ii)
is receiving a veteran’s pension under section 164 of the Act.
(2)
The amount is $5,791.47.
(3)
However, if the veteran was, before 1 April 1990, receiving a war veteran’s allowance under the War Pensions Act 1954, the amount is $14,602.73.
44 Lump sum payment on death of spouse or partner of veteran
(1)
This regulation specifies the amount payable under section 174(4) of the Act on the death of the spouse or partner of a veteran if, on the date of death, the spouse or partner—
(a)
is ordinarily resident in New Zealand; and
(b)
is receiving a veteran’s pension under section 162(2) of the Act.
(2)
The amount is $4,416.16.
Part 5 Regulations relating to Part 7 of Act
44A Transport costs associated with assessment
(1)
VANZ must pay a veteran’s or other claimant’s transport costs under this regulation if the veteran or other claimant is required to undergo a medical assessment in accordance with section 221(3) of the Act.
(2)
VANZ must pay the veteran or other claimant—
(a)
any fares paid for public transport for a journey:
(b)
for a journey in a private vehicle, $0.62 for each kilometre for the first 200 kilometres of the journey:
(c)
if VANZ approves payment for air fares for a journey before the veteran or other claimant undertakes the journey, any air fares paid for the journey.
(3)
In subclause (2), journey—
(a)
means a journey from a veteran’s or other claimant’s residence to the place of assessment by the most direct route and the return journey from that place (if the veteran or other claimant makes a return journey); but
(b)
does not include any international part of a journey described in paragraph (a).
Regulation 44A: inserted, on 7 December 2015, by regulation 11 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
45 Procedure for appeals against review decisions
Regulations 46 to 53 prescribe the procedure relating to appeals against review decisions for the purposes of subpart 2 of Part 7 of the Act.
46 Interpretation
In this Part, unless the context otherwise requires,—
evidence means any evidence or information, whether or not that evidence or information would be admissible in a court of law
party—
(a)
means a party to an appeal; and
(b)
includes VANZ.
47 VANZ must advise applicant of right to appeal
VANZ must, when notifying the outcome of a review decision to the person who applied for the review, advise the person—
(a)
of the right to appeal the review decision; and
(b)
of the time limit for bringing an appeal; and
(c)
that the person can obtain the form of the notice of appeal directly from VANZ or from VANZ’s Internet site.
48 Notice of appeal
(1)
The notice of appeal must be made in writing and in the form provided by VANZ for the purpose.
(2)
The notice of appeal must specify—
(a)
the review decision under appeal; and
(b)
the grounds for the appeal.
(3)
The notice of appeal must contain the following information:
(a)
the full name of the veteran or other claimant; and
(b)
a postal, physical, or electronic address to which information and notices concerning the appeal can be delivered to the appellant; and
(c)
whether the veteran or other claimant proposes to attend the hearing; and
(d)
any other information required by the form provided by VANZ for the purpose.
(4)
The form provided by VANZ may require the appellant to specify any evidence on which the appellant intends to rely for the appeal.
49 Notice of hearing
(1)
The appeal board must set a date and location for the hearing of an appeal.
(2)
Not later than 20 working days before the hearing date, the appeal board must notify the parties of the hearing date and location of the hearing.
50 Case management conferences and directions
(1)
The appeal board may hold a case management conference at any time.
(2)
If the appeal board considers that it will secure the just, speedy, and inexpensive determination of an appeal, or it is otherwise in the interests of justice, the appeal board may give a direction in relation to the management of the case.
(3)
A direction under subclause (2) may be given on the appeal board’s own initiative, or on the application of a party.
51 Evidence
(1)
Each party must, not later than 10 working days before the hearing date, provide all evidence on which that party wishes to rely at the hearing to the other party.
(2)
However, a party may provide further evidence at a later date in accordance with a direction given by the appeal board under regulation 50(2).
(3)
After determining an appeal, the appeal board must return all evidence provided to it by the veteran or other claimant, if the veteran or other claimant so requires.
(4)
To avoid doubt, VANZ may keep copies of any evidence provided to it.
52 Appellant not giving oral evidence
(1)
This regulation applies if the appellant does not provide oral evidence (whether by attending the hearing or remotely by electronic means).
(2)
If the appeal board decides that it cannot determine the appeal without hearing oral evidence from the appellant, the appeal is to be treated as having lapsed, but the appeal board may (on the application of the appellant) revive the appeal.
(3)
If the appeal board decides that it can determine the appeal without hearing oral evidence from the appellant, the appeal board may proceed to determine the appeal.
(4)
The appeal board must not make a decision under subclause (2) or (3) unless it has given the appellant—
(a)
prior notice that it is considering making the decision; and
(b)
a reasonable opportunity to respond.
53 Appeal may continue on death of veteran or other claimant
If a veteran or other claimant dies before his or her appeal has been determined, the appeal may be continued by his or her personal representative or by any other suitable person.
Part 6 Regulations relating to Part 8 of Act
Procedure of Veterans’ Advisory Board and Veterans’ Health Advisory Panel
54 Interpretation
(1)
In this Part, unless the context otherwise requires,—
advisory body means the Veterans’ Advisory Board or the Veterans’ Health Advisory Panel
chairperson—
(a)
means the chairperson of an advisory body; and
(b)
includes the acting chairperson of an advisory body, if one has been appointed under section 248(4) or 255(5) of the Act (as applicable)
deputy chairperson means the deputy chairperson of an advisory body
matter means an advisory body’s performance of its functions or exercise of its powers
member—
(a)
means a member of an advisory body; and
(b)
includes the chairperson and the deputy chairperson of the advisory body.
(2)
In this Part, a member is interested in a matter if he or she—
(a)
may derive a financial benefit from the matter; or
(b)
is the spouse, civil union partner, de facto partner, child, or parent of a person who may derive a financial benefit from the matter; or
(c)
may have a financial interest in a person to whom the matter relates; or
(d)
is a partner, director, officer, board member, or trustee of a person who may have a financial interest in a person to whom the matter relates; or
(e)
is otherwise directly or indirectly interested in the matter.
(3)
However, a member is not interested in a matter—
(a)
only because he or she receives an entitlement under the Act; or
(b)
if his or her interest is so remote or insignificant that it cannot reasonably be regarded as likely to influence him or her in carrying out his or her responsibilities under the Act; or
(c)
only because he or she has past or current involvement in the defence sector, in medical research, or in veterans’ matters.
Meetings
55 Notice of meetings
(1)
An advisory body or the chairperson (or, if there is no chairperson or the chairperson is unavailable, the deputy chairperson) must appoint the times and places of ordinary meetings of the advisory body, and VANZ must give written notice of those meetings to each member.
(2)
Notice of a meeting—
(a)
must state the time and place of the meeting; and
(b)
must be sent to each member’s current postal or electronic address.
(3)
An irregularity in the notice of a meeting is waived if all members entitled to receive the notice—
(a)
attend the meeting without protesting about the irregularity; or
(b)
do not attend the meeting, but agree before the meeting is held to waive the irregularity.
Compare: 2004 No 115 Schedule 5 cl 7
56 Methods of holding meetings
A meeting of an advisory body may be held—
(a)
by a quorum of members being assembled together at the time and place appointed for the meeting; or
(b)
by means of audio, audiovisual, or electronic communication if—
(i)
all of the members who wish to participate in the meeting have access to the technology needed to participate in the meeting; and
(ii)
a quorum of members can simultaneously communicate with each other throughout the meeting.
Compare: 2004 No 115 Schedule 5 cl 8
57 Unanimous written resolutions
A resolution signed or assented to in writing (whether by post, delivery, or electronic communication) by all members who are entitled to vote on the matter is as valid and effectual as if it had been passed unanimously at a meeting of the advisory body duly called and constituted.
Compare: 2004 No 115 Schedule 5 cl 13
Disclosure of interests
58 Obligation to disclose interest
(1)
A member who is interested in a matter relating to an advisory body must disclose details of the interest in accordance with regulation 59 as soon as practicable after the member becomes aware that he or she is interested.
(2)
A general notice of an interest in a matter relating to an advisory body, or in a matter that may in future relate to an advisory body, that is disclosed in accordance with regulation 59 is a standing disclosure of that interest for the purposes of this regulation.
(3)
A standing disclosure ceases to have effect if the nature of the interest materially alters or the extent of the interest materially increases.
Compare: 2004 No 115 s 63
59 Who disclosure of interests must be made to
The member must disclose details of the interest in an interests register kept by VANZ and to—
(a)
the chairperson or, if there is no chairperson or if the chairperson is unavailable or interested, the deputy chairperson; or
(b)
the Minister, if there is neither a chairperson nor a deputy chairperson, or if both the chairperson and the deputy chairperson are unavailable or interested.
Compare: 2004 No 115 s 64
60 What must be disclosed
The details that must be disclosed under regulation 59 are—
(a)
the nature of the interest and the monetary value of the interest (if the monetary value can be quantified); or
(b)
the nature and extent of the interest (if the monetary value cannot be quantified).
Compare: 2004 No 115 s 65
61 Consequences of being interested in matter
(1)
A member who is interested in a matter relating to an advisory body—
(a)
must not vote or take part in any discussion of the advisory body in relation to the matter, or otherwise participate in any activity of the advisory body in relation to the matter; and
(b)
must not take part in any decision of the advisory body in relation to the matter or sign or otherwise endorse any document containing the advisory body’s advice, comments, or decisions relating to the matter; and
(c)
is to be disregarded for the purpose of forming a quorum for that part of a meeting of the advisory body during which a discussion or decision relating to the matter occurs or is made.
(2)
This regulation is subject to regulation 63.
Compare: 2004 No 115 s 66
62 Consequences of failing to disclose interest
The advisory body must notify the Minister of a failure to comply with regulation 58 or 61, and of the affected matters or acts, as soon as practicable after becoming aware of the failure.
Compare: 2004 No 115 s 67
63 Permission to act despite being interested in matter
(1)
The chairperson may, by prior written notice to the advisory body or by a ruling during a meeting, permit 1 or more members, or members with a specified class of interest, to take part in any discussion (but not in any decision) of the advisory body in relation to the matter to which the interest relates if the chairperson is satisfied that it is in the public interest to do so.
(2)
The permission may state conditions that the member or members must comply with.
(3)
The deputy chairperson may give the permission if there is no chairperson or if the chairperson is unavailable or interested.
(4)
The Minister may give the permission if there is neither a chairperson nor a deputy chairperson, or if both the chairperson and the deputy chairperson are unavailable or interested.
(5)
A permission may be amended or revoked in the same way as it was given.
(6)
The advisory body must disclose an interest to which a permission relates in every document to which the interest relates, together with a statement of who gave the permission and any conditions of, amendments to, or revocation of the permission.
Compare: 2004 No 115 s 68
Part 7 Regulations relating to Part 9 of Act
Treatment cards
64 Issue of treatment card
VANZ may issue a treatment card to a veteran if the veteran has an injury, illness, or condition—
(a)
that is service-related; and
(b)
for which VANZ will pay or contribute towards the cost of treatment.
65 Information to be included on treatment card
A treatment card issued to a veteran must include the following information:
(a)
the veteran’s—
(i)
full name; and
(ii)
VANZ reference number; and
(iii)
Defence Force number (if applicable); and
(iv)
national health index number:
(b)
the card’s date of issue:
(c)
the card’s date of expiry (if issued for a limited period):
(d)
a description of the injuries, illnesses, or conditions that the veteran has and for which VANZ will pay or contribute towards the cost of treatment:
(e)
how to contact VANZ:
(f)
a statement to the effect that—
(i)
VANZ will pay or contribute towards (whichever is applicable) the cost of treatment of the service-related injuries, illnesses, or conditions described on the card; but
(ii)
VANZ will not pay or contribute towards the cost of specialist treatment unless VANZ has given its prior approval.
66 Obligations of treatment card holders
A veteran to whom a treatment card is issued must—
(a)
use the card only as evidence of the service-related injuries, illnesses, or conditions described on the card that the veteran has and for which VANZ will pay or contribute towards the cost of treatment; and
(b)
comply with the conditions specified in regulation 67; and
(c)
comply with all other requirements and restrictions relating to the use of treatment cards specified in regulations 68 and 69.
67 Conditions of use
(1)
If a veteran’s treatment card is lost, stolen, or destroyed, the veteran must (as soon as possible after becoming aware that this has happened) tell VANZ that his or her treatment card has been lost, stolen, or destroyed.
(2)
A veteran must return his or her treatment card to VANZ as soon as possible if—
(a)
the treatment card is damaged; or
(b)
VANZ has requested (in writing) the veteran to return the card to VANZ.
(3)
A veteran must not add to, amend, or remove any information recorded on a treatment card.
(4)
A veteran must comply with any other requirement that—
(a)
is notified in writing by VANZ to the veteran; and
(b)
is reasonably necessary for the use of the treatment card or treatment cards generally.
68 Unauthorised uses of treatment card
(1)
A treatment card must not—
(a)
be used for any dishonest or improper purpose; or
(b)
be used after a veteran has received a notice in writing from VANZ recalling or cancelling the treatment card; or
(c)
be given, lent, or sold to another person.
(2)
However, subclause (1)(c) does not apply if a treatment card is given to another person to obtain, on behalf of a veteran, a service to which the veteran is entitled.
69 Recall of treatment card
VANZ may require a veteran to return a treatment card if—
(a)
the information on the card needs to be changed; or
(b)
the veteran is no longer entitled to the card; or
(c)
VANZ considers, on reasonable grounds, that the veteran—
(i)
has not complied with the conditions relating to the use of the card; or
(ii)
has used the card for an unauthorised purpose.
70 Cancellation of treatment card
(1)
VANZ may cancel a veteran’s treatment card by notice in writing to the veteran if VANZ considers, on reasonable grounds, that—
(a)
the veteran is not entitled to the treatment card; or
(b)
the veteran has asked VANZ to cancel the treatment card; or
(c)
the veteran has, without good reason, refused to return the card after VANZ has requested its return; or
(d)
the veteran has not complied with the conditions relating to the use of the card; or
(e)
the veteran has used the card for an unauthorised purpose.
(2)
VANZ may not cancel a treatment card under subclause (1)(a), (c), (d), or (e) unless it has—
(a)
given the veteran notice in writing—
(i)
that it proposes to cancel the card; and
(ii)
of the grounds for the proposed cancellation; and
(b)
given the veteran a reasonable opportunity to provide VANZ with any reasons why it should not cancel the card; and
(c)
carefully considered any reasons provided under paragraph (b).
Part 8 Regulations relating to Schedule 2 of Act
Part 8: replaced, on 7 December 2015, by regulation 12 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
70A Allowances and annuity payable under Part 1 of Schedule 1 of Act
[Revoked]Regulation 70A: revoked, on 7 December 2015, by regulation 12 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Weekly compensation
Heading: replaced, on 7 December 2015, by regulation 12 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
71 Indexation of weekly compensation applies from date of indexation
(1)
Weekly compensation payable under section 100 of the Act must be adjusted in accordance with the formula set out in regulation 15A.
(2)
Adjustments made under regulation 15A apply only to weekly compensation—
(a)
that is paid or payable on or after the date of indexation; and
(b)
that relates to a period of incapacity for which the veteran is entitled to weekly compensation that occurs on or after the date of indexation.
(3)
Despite subclause (2), adjustments made under this regulation may be made to weekly compensation that relates to a period that occurs on or after the date that is 6 days earlier than the date of indexation.
Regulation 71: replaced, on 7 December 2015, by regulation 12 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Abatement of weekly compensation
Heading: inserted, on 7 December 2015, by regulation 12 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
72 Procedure for adjustments where weekly compensation subject to abatement
(1)
The adjustment under regulation 15A of weekly compensation that must be abated under clause 44 of Schedule 2 of the Act is determined by—
(a)
adjusting the appropriate unabated amount of weekly compensation in accordance with subclause (2); and
(b)
adjusting the amount of a person’s weekly earnings, as referred to in clause 44 of Schedule 2 of the Act, in accordance with subclause (3); and
(c)
applying clause 44 of Schedule 2 of the Act in accordance with subclause (4).
First adjustment
(2)
The amount of weekly compensation to which a veteran would be entitled but for an abatement under clause 44 of Schedule 2 of the Act must be adjusted in accordance with the formula set out in regulation 15A.
Second adjustment
(3)
The amount of the veteran’s weekly earnings must be adjusted at the date of indexation in accordance with the formula set out in regulation 15A.
Third adjustment
(4)
The amount of abated weekly compensation payable must be calculated in accordance with clause 44 of Schedule 2 of the Act, using the amounts as adjusted by subclauses (2) and (3).
Regulation 72: inserted, on 7 December 2015, by regulation 12 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Child care payments
Heading: inserted, on 7 December 2015, by regulation 12 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
73 Weekly entitlement to child care payments
(1)
This regulation specifies the amount of the weekly entitlement to payment for child care that is payable under clause 64 of Schedule 2 of the Act.
(2)
The weekly entitlement to payment for child care per child is as follows:
(a)
if the number of children of a deceased veteran entitled to payment for child care is 1, $164.72:
(b)
if the number of children of a deceased veteran entitled to payment for child care is 2, $98.82:
(c)
if the number of children of a deceased veteran entitled to payment for child care is 3 or more, $230.62 divided by the number of children of the veteran for whom payment is being made.
Regulation 73: inserted, on 7 December 2015, by regulation 12 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Part 9 Miscellaneous provisions
Part 9: inserted, on 7 December 2015, by regulation 12 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Allowance payable under Part 1 of Schedule 1 of Act
Heading: inserted, on 7 December 2015, by regulation 12 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
Heading: amended, on 1 April 2017, by regulation 5 of the Veterans’ Support Amendment Regulations 2017 (LI 2017/37).
74 Allowance payable under Part 1 of Schedule 1 of Act
The amount of the allowance payable under section 29A of the War Pensions Act 1954 and regulation 39A of the War Pensions Regulations 1956, and under Part 1 of Schedule 1 of the Act, is $32.61 a week.
Regulation 74: replaced, on 1 April 2017, by regulation 6 of the Veterans’ Support Amendment Regulations 2017 (LI 2017/37).
Regulation 74: amended, on 1 April 2019, by regulation 5 of the Veterans’ Support Amendment Regulations 2019 (LI 2019/44).
Schedule 1 Australian statements of principles that apply for purposes of Act
Schedule 1: replaced, on 14 October 2021, by regulation 4 of the Veterans’ Support Amendment Regulations (No 5) 2021 (LI 2021/260).
| Number | ||||
|---|---|---|---|---|
| Condition | Reasonable hypothesis | Balance of probabilities | ||
| accidental hypothermia | 21/2018 | 22/2018 | ||
| accommodation disorder | 38/2017 | 39/2017 | ||
| Achilles tendinopathy | 86/2024 | 87/2024 | ||
| acoustic neuroma | 96/2019 | 97/2019 | ||
| acquired cataract | 87/2016 | 88/2016 | ||
| acute articular cartilage tear | 21/2019 | 22/2019 | ||
| acute infectious mononucleosis | 17/2021 | 18/2021 | ||
| acute lymphoblastic leukaemia/lymphoblastic lymphoma | 33/2021 | 34/2021 | ||
| acute meniscal tear of the knee | 25/2019 | 26/2019 | ||
| acute myeloid leukaemia | 21/2024 | 22/2024 | ||
| acute pancreatitis | 5/2020 | 6/2020 | ||
| acute rheumatic fever | 53/2019 | 54/2019 | ||
| acute stress disorder | 95/2022 | 96/2022 | ||
| adhesive capsulitis of the shoulder | 72/2020 | 73/2020 | ||
| adjustment disorder | 58/2025 | 59/2025 | ||
| adrenal insufficiency | 71/2018 | 72/2018 | ||
| albinism | 31/2023 | 32/2023 | ||
| alcohol use disorder | 48/2017 | 49/2017 | ||
| allergic contact dermatitis | 1/2021 | 2/2021 | ||
| allergic rhinitis | 111/2022 | 112/2022 | ||
| alpha-1 antitrypsin deficiency | 33/2023 | 34/2023 | ||
| Alzheimer disease | 33/2019 | 34/2019 | ||
| anal fissure | 87/2019 | 88/2019 | ||
| analgesic nephropathy | 43/2025 | 44/2025 | ||
| angle-closure glaucoma | 5/2021 | 6/2021 | ||
| animal envenomation | 81/2016 | 82/2016 | ||
| ankylosing spondylitis | 39/2021 | 40/2021 | ||
| anosmia | 19/2021 | 20/2021 | ||
| anxiety disorder | 100/2023 | 101/2023 | ||
| aortic aneurysm and aortic wall disorders | 21/2021 | 22/2021 | ||
| aortic stenosis | 13/2022 | 14/2022 | ||
| aplastic anaemia | 58/2020 | 59/2020 | ||
| arachnoid cyst | 11/2025 | 12/2025 | ||
| asbestosis | 59/2021 | 60/2021 | ||
| ascariasis | 9/2017 | 10/2017 | ||
| asthma | 31/2021 | 32/2021 | ||
| atrial fibrillation and atrial flutter | 1/2023 | 2/2023 | ||
| autosomal dominant polycystic kidney disease | 35/2023 | 36/2023 | ||
| Barrett’s oesophagus | 67/2016 | 68/2016 | ||
| benign neoplasm of the eye and adnexa | 62/2025 | 63/2025 | ||
| benign paroxysmal positional vertigo | 56/2017 | 57/2017 | ||
| benign prostatic hyperplasia | 13/2025 | 14/2025 | ||
| bipolar disorder | 53/2018 | 54/2018 | ||
| blepharitis | 29/2019 | 30/2019 | ||
| bronchiectasis | 30/2017 | 31/2017 | ||
| bronchiolitis obliterans organising pneumonia | 79/2018 | 80/2018 | ||
| bruxism | 91/2016 | 92/2016 | ||
| cardiac myxoma | 32/2017 | 33/2017 | ||
| cardiomyopathy | 57/2024 | 58/2024 | ||
| carotid artery disease | 54/2020 | 55/2020 | ||
| carpal tunnel syndrome | 93/2021 | 94/2021 | ||
| central serous chorioretinopathy | 45/2018 | 46/2018 | ||
| cerebral meningioma | 1/2018 | 2/2018 | ||
| cerebrovascular accident (stroke) | 45/2024 | 46/2024 | ||
| cervical dystonia (spasmodic torticollis) | 41/2025 | 42/2025 | ||
| cervical intervertebral disc prolapse | 66/2023 | 67/2023 | ||
| cervical spondylosis | 11/2023 | 12/2023 | ||
| Charcot-Marie-Tooth disease | 88/2023 | 89/2023 | ||
| chemical burn | 3/2024 | 4/2024 | ||
| chickenpox | 29/2023 | 30/2023 | ||
| chilblains | 29/2018 | 30/2018 | ||
| chloracne | 62/2020 | 63/2020 | ||
| cholelithiasis | 51/2016 | 52/2016 | ||
| chondromalacia patella | 1/2019 | 2/2019 | ||
| chronic exertional compartment syndrome of the lower leg | 98/2023 | 99/2023 | ||
| chronic fatigue syndrome | 105/2021 | 106/2021 | ||
| chronic gastritis and chronic gastropathy | 101/2021 | 102/2021 | ||
| chronic insomnia disorder | 37/2019 | 38/2019 | ||
| chronic multisymptom illness | 3/2020 | 4/2020 | ||
| chronic myeloid leukaemia | 57/2023 | 58/2023 | ||
| chronic obstructive pulmonary disease | 17/2023 | 18/2023 | ||
| chronic pancreatitis | 64/2020 | 65/2020 | ||
| chronic pruritus ani | 31/2019 | 32/2019 | ||
| chronic solvent-induced neurocognitive disorder | 109/2021 | 110/2021 | ||
| chronic venous insufficiency of the lower limb and varicose veins of the lower limb | 7/2021 | 8/2021 | ||
| cirrhosis of the liver | 1/2017 | 2/2017 | ||
| clonorchiasis | 25/2025 | 26/2025 | ||
| cluster headache | 57/2018 | 58/2018 | ||
| coeliac disease | 29/2020 | 30/2020 | ||
| colorectal adenoma | 15/2022 | 16/2022 | ||
| complex regional pain syndrome | 97/2016 | 98/2016 | ||
| concussion | 92/2018 | 93/2018 | ||
| conductive hearing loss | 81/2019 | 82/2019 | ||
| conjunctivitis | 76/2020 | 77/2020 | ||
| coronavirus disease 2019 (COVID-19) | 46/2020 | 47/2020 | ||
| Creutzfeldt-Jakob disease | 80/2022 | 81/2022 | ||
| Cushing syndrome | 43/2018 | 44/2018 | ||
| cut, stab, abrasion and laceration | 37/2025 | 38/2025 | ||
| de Quervain tendinopathy | 41/2019 | 42/2019 | ||
| decompression illness | 23/2023 | 24/2023 | ||
| deep vein thrombosis | 35/2021 | 36/2021 | ||
| dementia pugilistica | 9/2021 | 10/2021 | ||
| dengue virus infection | 78/2020 | 79/2020 | ||
| dental malocclusion | 19/2019 | 20/2019 | ||
| dental pulp and periapical disease | 99/2021 | 100/2021 | ||
| depressive disorder | 11/2024 | 12/2024 | ||
| dermatomyositis | 70/2022 | 71/2022 | ||
| diabetes mellitus | 48/2020 | 49/2020 | ||
| diaphragmatic hernia | 99/2022 | 100/2022 | ||
| discoid lupus erythematosus | 49/2025 | 50/2025 | ||
| dislocation of a joint and subluxation of a joint | 55/2019 | 56/2019 | ||
| distal biceps brachii tendinopathy | 3/2025 | 4/2025 | ||
| diverticular disease of the colon | 51/2025 | 52/2025 | ||
| duodenal ulcer and duodenal erosion | 49/2024 | 50/2024 | ||
| Dupuytren disease | 9/2019 | 10/2019 | ||
| eating disorder | 15/2025 | 16/2025 | ||
| electrical injury | 41/2018 | 42/2018 | ||
| endometriosis | 51/2021 | 52/2021 | ||
| eosinophilic oesophagus | 29/2022 | 30/2022 | ||
| epicondylitis | 5/2023 | 6/2023 | ||
| epilepsy | 84/2022 | 85/2022 | ||
| erectile dysfunction | 72/2022 | 73/2022 | ||
| essential thrombocythaemia | 91/2021 | 92/2021 | ||
| exertional heat illness | 31/2022 | 32/2022 | ||
| explosive blast injury | 25/2020 | 26/2020 | ||
| familial adenomatous polyposis | 77/2021 | 78/2021 | ||
| female sexual dysfunction | 95/2016 | 96/2016 | ||
| femoroacetabular impingement syndrome | 42/2017 | 43/2017 | ||
| fibromuscular dysplasia | 79/2016 | 80/2016 | ||
| fibromyalgia | 107/2021 | 108/2021 | ||
| fibrosing interstitial lung disease | 85/2021 | 86/2021 | ||
| fracture | 62/2024 | 63/2024 | ||
| frostbite | 11/2018 | 12/2018 | ||
| ganglion | 7/2025 | 8/2025 | ||
| gastric ulcer and gastric erosion | 51/2024 | 52/2024 | ||
| gastro-oesophageal reflux disease | 61/2021 | 62/2021 | ||
| Gaucher disease | 37/2023 | 38/2023 | ||
| gender dysphoria | 113/2021 | 114/2021 | ||
| giant cell arteritis | 11/2021 | 12/2021 | ||
| gingivitis | 17/2022 | 18/2022 | ||
| gluteal tendinopathy | 94/2023 | 95/2023 | ||
| goitre | 9/2022 | 10/2022 | ||
| gout | 59/2019 | 60/2019 | ||
| Graves disease | 7/2022 | 8/2022 | ||
| Guillain-Barre syndrome | 23/2018 | 24/2018 | ||
| gunshot injury | 23/2020 | 24/2020 | ||
| haemophilia | 39/2023 | 40/2023 | ||
| haemorrhoids | 3/2017 | 4/2017 | ||
| hallux valgus | 25/2024 | 26/2024 | ||
| Hashimoto thyroiditis | 1/2022 | 2/2022 | ||
| heart block | 23/2022 | 24/2022 | ||
| heat-induced burn | 1/2024 | 2/2024 | ||
| hepatitis A infection | 9/2024 | 10/2024 | ||
| hepatitis B | 13/2017 | 14/2017 | ||
| hepatitis C | 13/2018 | 14/2018 | ||
| hepatitis D | 11/2017 | 12/2017 | ||
| hepatitis E infection | 39/2024 | 40/2024 | ||
| hereditary haemochromatosis | 23/2021 | 24/2021 | ||
| hereditary spherocytosis | 41/2023 | 42/2023 | ||
| herpes simplex | 39/2018 | 40/2018 | ||
| hiatus hernia | 60/2022 | 61/2022 | ||
| Hodgkin lymphoma | 70/2023 | 71/2023 | ||
| hookworm disease | 7/2017 | 8/2017 | ||
| human immunodeficiency virus infection | 5/2019 | 6/2019 | ||
| human T-cell lymphotropic virus type-1 infection | 96/2018 | 97/2018 | ||
| Huntington disease | 49/2023 | 50/2023 | ||
| hyperacusis | 27/2021 | 28/2021 | ||
| hypersensitivity pneumonitis | 7/2020 | 8/2020 | ||
| hypertension | 21/2022 | 22/2022 | ||
| hyperthyroidism and thyrotoxicosis | 5/2022 | 6/2022 | ||
| hypogonadism | 73/2021 | 74/2021 | ||
| hypopituitarism | 11/2019 | 12/2019 | ||
| hypothyroidism | 3/2022 | 4/2022 | ||
| IgA nephropathy | 63/2021 | 64/2021 | ||
| iliotibial band syndrome | 3/2019 | 4/2019 | ||
| immersion pulmonary oedema | 34/2017 | 35/2017 | ||
| immune thrombocytopaenia | 63/2017 | 64/2017 | ||
| incisional hernia | 73/2016 | 74/2016 | ||
| inflammatory bowel disease | 90/2020 | 91/2020 | ||
| influenza | 44/2017 | 45/2017 | ||
| ingrown nail | 72/2024 | 73/2024 | ||
| inguinal hernia | 47/2021 | 48/2021 | ||
| internal derangement of the knee | 7/2019 | 8/2019 | ||
| irritable bowel syndrome | 65/2019 | 66/2019 | ||
| irritant contact dermatitis | 3/2021 | 4/2021 | ||
| ischaemic heart disease | 27/2025 | 28/2025 | ||
| joint instability | 57/2019 | 58/2019 | ||
| Kaposi sarcoma | 1/2020 | 2/2020 | ||
| knee bursitis | 65/2018 | 66/2018 | ||
| labral tear | 36/2017 | 37/2017 | ||
| leptospirosis | 101/2022 | 102/2022 | ||
| localised sclerosis | 61/2018 | 62/2018 | ||
| Lyme disease/Lyme borreliosis | 17/2025 | 18/2025 | ||
| macular degeneration | 59/2018 | 60/2018 | ||
| malaria | 46/2017 | 47/2017 | ||
| malignant melanoma of the skin | 34/2024 | 35/2024 | ||
| malignant neoplasm of bone and articular cartilage | 66/2020 | 67/2020 | ||
| malignant neoplasm of the anus and anal canal | 82/2022 | 83/2022 | ||
| malignant neoplasm of the bile duct | 53/2024 | 54/2024 | ||
| malignant neoplasm of the bladder | 83/2019 | 84/2019 | ||
| malignant neoplasm of the brain | 85/2016 | 86/2016 | ||
| malignant neoplasm of the breast | 84/2023 | 85/2023 | ||
| malignant neoplasm of the cerebral meninges | 3/2018 | 4/2018 | ||
| malignant neoplasm of the cervix | 80/2020 | 81/2020 | ||
| malignant neoplasm of the colon and rectum | 19/2022 | 20/2022 | ||
| malignant neoplasm of the endometrium | 31/2025 | 32/2025 | ||
| malignant neoplasm of the eye | 27/2018 | 28/2018 | ||
| malignant neoplasm of the gallbladder | 36/2024 | 37/2024 | ||
| malignant neoplasm of the kidney | 41/2021 | 42/2021 | ||
| malignant neoplasm of the larynx | 41/2022 | 42/2022 | ||
| malignant neoplasm of the liver | 31/2020 | 32/2020 | ||
| malignant neoplasm of the lung | 86/2023 | 87/2023 | ||
| malignant neoplasm of the nasopharynx | 9/2020 | 10/2020 | ||
| malignant neoplasm of the oesophagus | 120/2015 | 121/2015 | ||
| malignant neoplasm of the oral cavity, oropharynx and hypopharynx | 65/2021 | 66/2021 | ||
| malignant neoplasm of the ovary | 9/2018 | 10/2018 | ||
| malignant neoplasm of the pancreas | 103/2021 | 104/2021 | ||
| malignant neoplasm of the prostate | 3/2023 | 4/2023 | ||
| malignant neoplasm of the renal pelvis and ureter | 92/2019 | 93/2019 | ||
| malignant neoplasm of the salivary gland | 102/2023 | 103/2023 | ||
| malignant neoplasm of the small intestine | 80/2023 | 81/2023 | ||
| malignant neoplasm of the stomach | 74/2023 | 75/2023 | ||
| malignant neoplasm of the testis and epididymis | 7/2024 | 8/2024 | ||
| malignant neoplasm of the thyroid gland | 39/2022 | 40/2022 | ||
| malignant neoplasm of the urethra | 19/2025 | 20/2025 | ||
| malignant neoplasm of unknown primary site | 103/2022 | 104/2022 | ||
| Marfan syndrome | 51/2023 | 52/2023 | ||
| mature B-cell lymphoid leukaemia and small lymphocytic lymphoma | 78/2022 | 79/2022 | ||
| medial tibial stress syndrome (shin splints) | 96/2023 | 97/2023 | ||
| melioidosis | 55/2023 | 56/2023 | ||
| Meniere disease and Meniere syndrome | 68/2024 | 69/2024 | ||
| Merkel cell carcinoma | 80/2024 | 81/2024 | ||
| mesenteric panniculitis | 49/2018 | 50/2018 | ||
| mesothelioma | 41/2024 | 42/2024 | ||
| methaemoglobinaemia | 17/2019 | 18/2019 | ||
| microscopic polyangiitis | 90/2019 | 91/2019 | ||
| migraine | 7/2018 | 8/2018 | ||
| mitral valve prolapse | 15/2023 | 16/2023 | ||
| moderate to severe traumatic brain injury | 94/2018 | 95/2018 | ||
| morbid obesity | 43/2022 | 44/2022 | ||
| Morton metatarsalgia | 77/2019 | 78/2019 | ||
| motor neurone disease | 111/2021 | 112/2021 | ||
| multiple osteochondromatosis | 43/2023 | 44/2023 | ||
| multiple sclerosis | 11/2020 | 12/2020 | ||
| myasthenia gravis | 32/2024 | 33/2024 | ||
| myelodysplastic neoplasm (syndrome) | 76/2024 | 77/2024 | ||
| myeloma | 95/2021 | 96/2021 | ||
| myocarditis | 17/2024 | 18/2024 | ||
| narcolepsy | 11/2022 | 12/2022 | ||
| neoplasm of the pituitary gland | 70/2024 | 71/2024 | ||
| neurocognitive disorder with Lewy bodies | 35/2019 | 36/2019 | ||
| non-aneurysmal aortic atherosclerotic disease | 52/2020 | 53/2020 | ||
| non-freezing cold injury | 5/2018 | 6/2018 | ||
| non-Hodgkin lymphoma | 90/2018 | 91/2018 | ||
| non-melanoma malignant neoplasm of the skin | 78/2024 | 79/2024 | ||
| obstructive and reflux nephropathy | 85/2019 | 86/2019 | ||
| olecranon bursitis | 63/2018 | 64/2018 | ||
| open-angle glaucoma | 49/2021 | 50/2021 | ||
| opisthorchiasis | 21/2025 | 22/2025 | ||
| optochiasmatic arachnoiditis | 57/2016 | 58/2016 | ||
| osteoarthritis | 61/2017 | 62/2017 | ||
| osteogenesis imperfecta | 53/2023 | 54/2023 | ||
| osteomyelitis | 23/2024 | 24/2024 | ||
| osteonecrosis | 13/2020 | 14/2020 | ||
| osteoporosis | 66/2024 | 67/2024 | ||
| otitic barotrauma | 86/2020 | 87/2020 | ||
| otitis externa | 25/2021 | 26/2021 | ||
| otitis media | 62/2022 | 63/2022 | ||
| otosclerosis | 23/2025 | 24/2025 | ||
| Paget disease of bone | 62/2023 | 63/2023 | ||
| panic disorder | 55/2018 | 56/2018 | ||
| Parkinson’s disease and secondary parkinsonism | 55/2016 | 56/2016 | ||
| patellar tendinopathy | 21/2020 | 22/2020 | ||
| pathological fracture | 64/2024 | 65/2024 | ||
| pericarditis | 90/2023 | 91/2023 | ||
| periodic limb movement disorder | 19/2023 | 20/2023 | ||
| periodontal abscess | 25/2022 | 26/2022 | ||
| periodontitis | 27/2022 | 28/2022 | ||
| peripheral artery disease | 70/2020 | 71/2020 | ||
| peripheral neuropathy | 72/2023 | 73/2023 | ||
| peritoneal adhesions | 9/2025 | 10/2025 | ||
| personality disorder | 17/2018 | 18/2018 | ||
| pes planus | 67/2021 | 68/2021 | ||
| photocontact dermatitis | 82/2020 | 83/2020 | ||
| pilonidal sinus | 27/2019 | 28/2019 | ||
| pinguecula | 60/2024 | 61/2024 | ||
| plantar fasciitis | 82/2023 | 83/2023 | ||
| plantar fibromatosis | 21/2023 | 22/2023 | ||
| pleural plaque | 105/2022 | 106/2022 | ||
| poisoning from plants or fungi | 49/2019 | 50/2019 | ||
| polyarteritis nodosa | 33/2020 | 34/2020 | ||
| polycythaemia vera | 87/2021 | 88/2021 | ||
| polymyalgia rheumatica | 5/2025 | 6/2025 | ||
| popliteal cyst | 31/2018 | 32/2018 | ||
| popliteal entrapment syndrome | 54/2017 | 55/2017 | ||
| porphyria cutanea tarda | 69/2021 | 70/2021 | ||
| portal vein thrombosis | 107/2022 | 108/2022 | ||
| posterior adventitial heel bursitis | 47/2019 | 48/2019 | ||
| posterior tibialis tendinopathy | 45/2021 | 46/2021 | ||
| posttraumatic stress disorder | 97/2022 | 98/2022 | ||
| primary myelofibrosis | 89/2021 | 90/2021 | ||
| psoriasis | 13/2021 | 14/2021 | ||
| psoriatic arthritis | 15/2021 | 16/2021 | ||
| pterygium | 33/2025 | 34/2025 | ||
| pulmonary barotrauma | 64/2023 | 65/2023 | ||
| pulmonary thromboembolism | 37/2021 | 38/2021 | ||
| pure red cell aplasia | 60/2020 | 61/2020 | ||
| radiation burn | 5/2024 | 6/2024 | ||
| rapidly progressive crescentic glomerulonephritis | 45/2019 | 46/2019 | ||
| reactive arthritis | 75/2018 | 76/2018 | ||
| relapsing polychondritis | 5/2017 | 6/2017 | ||
| renal artery atherosclerotic disease | 56/2020 | 57/2020 | ||
| renal stone disease | 69/2019 | 70/2019 | ||
| restless legs syndrome | 113/2022 | 114/2022 | ||
| retinal burn | 25/2023 | 26/2023 | ||
| retinal vascular occlusion | 50/2020 | 51/2020 | ||
| retrocalcaneal heel bursitis | 88/2024 | 89/2024 | ||
| rheumatic heart disease | 51/2019 | 52/2019 | ||
| rheumatoid arthritis | 50/2017 | 51/2017 | ||
| Ross River virus infection | 94/2019 | 95/2019 | ||
| rotator cuff syndrome | 109/2022 | 110/2022 | ||
| sarcoidosis | 60/2025 | 61/2025 | ||
| Scheuermann’s disease (kyphosis) | 45/2025 | 46/2025 | ||
| schistosomiasis | 61/2019 | 62/2019 | ||
| schizophrenia | 83/2016 | 84/2016 | ||
| scrub typhus | 77/2018 | 78/2018 | ||
| seborrhoeic dermatitis | 43/2021 | 44/2021 | ||
| seborrhoeic keratosis | 19/2024 | 20/2024 | ||
| seizure | 37/2022 | 38/2022 | ||
| sensorineural hearing loss | 98/2019 | 99/2019 | ||
| shingles and postherpetic neuralgia | 27/2023 | 28/2023 | ||
| sick sinus syndrome | 66/2022 | 67/2022 | ||
| sickle-cell disorder | 40/2017 | 41/2017 | ||
| sinus barotrauma | 23/2019 | 24/2019 | ||
| sinusitis | 73/2018 | 74/2018 | ||
| sleep apnoea | 68/2022 | 69/2022 | ||
| smallpox | 89/2016 | 90/2016 | ||
| soft tissue sarcoma | 76/2023 | 77/2023 | ||
| solar keratosis | 79/2021 | 80/2021 | ||
| somatic symptom disorder | 64/2022 | 65/2022 | ||
| spinal adhesive arachnoiditis | 74/2020 | 75/2020 | ||
| spondylolisthesis and spondylolysis | 56/2025 | 57/2025 | ||
| sprain and strain | 27/2020 | 28/2020 | ||
| steatohepatitis | 86/2022 | 87/2022 | ||
| strongyloidiasis | 63/2019 | 64/2019 | ||
| subarachnoid haemorrhage | 67/2019 | 68/2019 | ||
| subcutaneous lipoma | 82/2024 | 83/2024 | ||
| subdural haematoma | 100/2019 | 101/2019 | ||
| substance use disorder | 59/2017 | 60/2017 | ||
| sudden unexplained death | 45/2022 | 46/2022 | ||
| suicide and attempted suicide | 39/2025 | 40/2025 | ||
| systemic lupus erythematosus | 47/2025 | 48/2025 | ||
| systemic sclerosis | 25/2018 | 26/2018 | ||
| tardive dyskinesia | 78/2023 | 79/2023 | ||
| temporomandibular disorder | 47/2018 | 48/2018 | ||
| tension-type headache | 37/2018 | 38/2018 | ||
| thoracic outlet syndrome | 47/2022 | 48/2022 | ||
| thoracolumbar intervertebral disc prolapse | 68/2023 | 69/2023 | ||
| thoracolumbar spondylosis | 13/2023 | 14/2023 | ||
| thromboangiitis obliterans | 28/2017 | 29/2017 | ||
| tinea | 55/2024 | 56/2024 | ||
| tinnitus | 84/2020 | 85/2020 | ||
| tooth decay (dental caries) | 74/2024 | 75/2024 | ||
| tooth loss | 29/2025 | 30/2025 | ||
| tooth wear | 52/2017 | 53/2017 | ||
| toxic retinopathy | 19/2018 | 20/2018 | ||
| toxic vestibulopathy | 88/2020 | 89/2020 | ||
| transverse myelitis | 71/2021 | 72/2021 | ||
| traumatic brachial plexopathy | 1/2025 | 2/2025 | ||
| traumatic contusion or haematoma | 43/2024 | 44/2024 | ||
| trigeminal neuralgia or trigeminal neuropathy | 84/2024 | 85/2024 | ||
| trigger finger | 39/2019 | 40/2019 | ||
| trochanteric bursitis | 92/2023 | 93/2023 | ||
| tuberculosis | 47/2024 | 48/2024 | ||
| ulnar neuropathy at the elbow | 65/2017 | 66/2017 | ||
| umbilical hernia | 93/2016 | 94/2016 | ||
| vaccine-induced thrombotic thrombocytopaenia | 33/2022 | 34/2022 | ||
| varicocoele | 79/2019 | 80/2019 | ||
| vascular neurocognitive disorder | 9/2023 | 10/2023 | ||
| visual refractive error | 35/2025 | 36/2025 | ||
| von Willebrand disease | 45/2023 | 46/2023 | ||
| warts | 7/2023 | 8/2023 | ||
| Wilson disease | 47/2023 | 48/2023 | ||
| Zika virus infection | 15/2018 | 16/2018 | ||
Schedule 1: amended, on 23 October 2025, by regulation 4 of the Veterans’ Support Amendment Regulations (No 3) 2025 (SL 2025/217).
Schedule 1: amended, on 26 June 2025, by regulation 4 of the Veterans’ Support Amendment Regulations (No 2) 2025 (SL 2025/124).
Schedule 1: amended, on 10 April 2025, by regulation 4 of the Veterans’ Support Amendment Regulations 2025 (SL 2025/43).
Schedule 1: amended, on 31 October 2024, by regulation 4 of the Veterans’ Support Amendment Regulations (No 3) 2024 (SL 2024/213).
Schedule 1: amended, on 27 June 2024, by regulation 4 of the Veterans’ Support Amendment Regulations (No 2) 2024 (SL 2024/91).
Schedule 1: amended, on 9 May 2024, by regulation 4 of the Veterans’ Support Amendment Regulations 2024 (SL 2024/38).
Schedule 1: amended, on 24 August 2023, by regulation 4 of the Veterans’ Support Amendment Regulations (No 2) 2023 (SL 2023/180).
Schedule 1: amended, on 11 May 2023, by regulation 4 of the Veterans’ Support Amendment Regulations 2023 (SL 2023/56).
Schedule 1: amended, on 12 January 2023, by regulation 4 of the Veterans’ Support Amendment Regulations (No 4) 2022 (SL 2022/329).
Schedule 1: amended, on 29 September 2022, by regulation 4 of the Veterans’ Support Amendment Regulations (No 3) 2022 (SL 2022/249).
Schedule 1: amended, on 22 April 2022, by regulation 4 of Veterans’ Support Amendment Regulations (No 2) 2022 (SL 2022/80).
Schedule 1: amended, on 20 January 2022, by regulation 4 of the Veterans’ Support Amendment Regulations (No 6) 2021 (SL 2021/437).
Schedule 2 Rate of disablement pension
| Level of whole-person impairment (%) | Weekly payment rate ($) | |
|---|---|---|
| 5–7 | 10.85 | |
| 8–12 | 21.70 | |
| 13–17 | 32.54 | |
| 18–22 | 43.39 | |
| 23–25 | 54.24 | |
| 26–30 | 65.09 | |
| 31–32 | 75.93 | |
| 33–37 | 86.78 | |
| 38–41 | 97.63 | |
| 42–47 | 108.48 | |
| 48–49 | 119.32 | |
| 50 | 130.17 | |
| 51 | 141.02 | |
| 52–54 | 151.87 | |
| 55–57 | 162.71 | |
| 58–61 | 173.56 | |
| 62–66 | 184.41 | |
| 67 | 195.26 | |
| 68–74 | 206.10 | |
| 75 | 216.95 | |
| 76 | 227.80 | |
| 77 | 238.65 | |
| 78 | 249.49 | |
| 79 | 260.34 | |
| 80 | 271.19 | |
| 81 | 292.88 | |
| 82 | 314.58 | |
| 83 | 336.27 | |
| 84 | 357.97 | |
| 85–100 | 381.83 |
Schedule 2A Accepted late-onset conditions
Schedule 2A: inserted, on 7 December 2015, by regulation 13 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
| Condition | |
|---|---|
| acoustic neuroma | |
| acute infectious mononucleosis | |
| acute lymphoblastic leukaemia/lymphoblastic lymphoma | |
| acute myeloid leukaemia | |
| acute pancreatitis | |
| acute rheumatic fever | |
| acute stress disorder | |
| adjustment disorder | |
| adrenal insufficiency | |
| alcohol use disorder | |
| alpha-1 antitrypsin deficiency | |
| Alzheimer disease | |
| analgesic nephropathy | |
| animal envenomation | |
| anxiety disorder | |
| aortic aneurysm and aortic wall disorders | |
| aortic stenosis | |
| aplastic anaemia | |
| asbestosis | |
| ascariasis | |
| asthma | |
| atherosclerotic peripheral vascular disease | |
| atrial fibrillation and atrial flutter | |
| autosomal dominant polycystic kidney disease | |
| bipolar disorder | |
| bronchiectasis | |
| cardiac myxoma | |
| cardiomyopathy | |
| carotid artery disease | |
| cerebral meningioma | |
| cerebrovascular accident (stroke) | |
| Charcot-Marie-Tooth disease | |
| chicken pox | |
| cholelithiasis | |
| chronic myeloid leukaemia | |
| chronic obstructive pulmonary disease | |
| chronic pancreatitis | |
| chronic solvent-induced neurocognitive disorder | |
| cirrhosis of the liver | |
| clonorchiasis | |
| coeliac disease | |
| colorectal adenoma | |
| Creutzfeldt-Jakob disease | |
| Cushing syndrome | |
| cut, stab, abrasion and laceration | |
| decompression illness | |
| deep vein thrombosis | |
| dementia pugilistica | |
| dengue virus infection | |
| depressive disorder | |
| dermatomyositis | |
| diabetes mellitus | |
| duodenal ulcer and duodenal erosion | |
| eating disorder | |
| electrical injury | |
| endometriosis | |
| epilepsy | |
| essential thrombocythaemia | |
| exertional heat illness | |
| explosive blast injury | |
| familial adenomatous polyposis | |
| fibromuscular dysplasia | |
| fibrosing interstitial lung disease | |
| gastric ulcer and gastric erosion | |
| Gaucher disease | |
| gender dysphoria | |
| giant cell arteritis | |
| Graves disease | |
| Guillain-Barre syndrome | |
| gunshot injury | |
| haemophilia | |
| Hashimoto thyroiditis | |
| heart block | |
| heat-induced burn | |
| hepatitis A infection | |
| hepatitis B | |
| hepatitis C | |
| hepatitis D | |
| hepatitis E infection | |
| hereditary haemochromatosis | |
| hereditary spherocytosis | |
| herpes simplex | |
| Hodgkin lymphoma | |
| hookworm disease | |
| human immunodeficiency virus infection | |
| human T-cell lymphotropic virus type-1 infection | |
| Huntington disease | |
| hypersensitivity pneumonitis | |
| hyperthyroidism and thyrotoxicosis | |
| hypogonadism | |
| hypopituitarism | |
| hypothyroidism | |
| IgA nephropathy | |
| immune thrombocytopaenia | |
| inflammatory bowel disease | |
| inguinal hernia | |
| ischaemic heart disease | |
| Kaposi sarcoma | |
| leptospirosis | |
| localised sclerosis | |
| malaria | |
| malignant melanoma of the skin | |
| malignant neoplasm of bone and articular cartilage | |
| malignant neoplasm of the anus and anal canal | |
| malignant neoplasm of the bile duct | |
| malignant neoplasm of the bladder | |
| malignant neoplasm of the brain | |
| malignant neoplasm of the breast | |
| malignant neoplasm of the cerebral meninges | |
| malignant neoplasm of the cervix | |
| malignant neoplasm of the colon and rectum | |
| malignant neoplasm of the endometrium | |
| malignant neoplasm of the eye | |
| malignant neoplasm of the gallbladder | |
| malignant neoplasm of the kidney | |
| malignant neoplasm of the larynx | |
| malignant neoplasm of the liver | |
| malignant neoplasm of the lung | |
| malignant neoplasm of the nasopharynx | |
| malignant neoplasm of the oesophagus | |
| malignant neoplasm of the oral cavity, oropharynx and hypopharynx | |
| malignant neoplasm of the ovary | |
| malignant neoplasm of the pancreas | |
| malignant neoplasm of the prostate | |
| malignant neoplasm of the renal pelvis and ureter | |
| malignant neoplasm of the salivary gland | |
| malignant neoplasm of the small intestine | |
| malignant neoplasm of the stomach | |
| malignant neoplasm of the testis and epididymis | |
| malignant neoplasm of the thyroid gland | |
| malignant neoplasm of the urethra | |
| malignant neoplasm of unknown primary site | |
| Marfan syndrome | |
| mature B-cell lymphoid leukaemia and small lymphocytic lymphoma | |
| melioidosis | |
| Merkel cell carcinoma | |
| mesenteric panniculitis | |
| mesothelioma | |
| methaemoglobinaemia | |
| microscopic polyangiitis | |
| moderate to severe traumatic brain injury | |
| motor neurone disease | |
| multiple osteochondromatosis | |
| multiple sclerosis | |
| myasthenia gravis | |
| myelodysplastic neoplasm (syndrome) | |
| myeloma | |
| myocarditis | |
| neoplasm of the pituitary gland | |
| neurocognitive disorder with Lewy bodies | |
| non-aneurysmal aortic atherosclerotic disease | |
| non-Hodgkin lymphoma | |
| non-melanoma malignant neoplasm of the skin | |
| obstructive and reflux neophropathy | |
| opisthorchiasis | |
| osteogenesis imperfecta | |
| osteomyelitis | |
| panic disorder | |
| Parkinson’s disease and secondary parkinsonism | |
| pericarditis | |
| peritoneal adhesions | |
| personality disorder | |
| poisoning from plants or fungi | |
| polyarteritis nodosa | |
| polycythaemia vera | |
| porphyria cutanea tarda | |
| portal vein thrombosis | |
| posttraumatic stress disorder | |
| primary myelofibrosis | |
| psoriasis | |
| pulmonary barotrauma | |
| pulmonary thromboembolism | |
| pure red cell aplasia | |
| rapidly progressive crescentic glomerulonephritis | |
| relapsing polychondritis | |
| renal artery atherosclerotic disease | |
| renal stone disease | |
| rheumatic heart disease | |
| rheumatoid arthritis | |
| Ross River virus infection | |
| sarcoidosis | |
| schistosomiasis | |
| schizophrenia | |
| scrub typhus | |
| seizure | |
| shingles and postherpetic neuralgia | |
| sick sinus syndrome | |
| sickle-cell disorder | |
| sinusitis | |
| sleep apnoea | |
| smallpox | |
| soft tissue sarcoma | |
| somatic symptom disorder | |
| steatohepatitis | |
| strongyloidiasis | |
| subarachnoid haemorrhage | |
| subdural haematoma | |
| substance use disorder | |
| suicide and attempted suicide | |
| systemic lupus erythematosus | |
| systemic sclerosis | |
| tinnitus | |
| thromboangiitis obliterans | |
| transverse myelitis | |
| tuberculosis | |
| vascular neurocognitive disorder | |
| von Willebrand disease | |
| Wilson disease |
Schedule 2A: amended, on 10 April 2025, by regulation 5 of the Veterans’ Support Amendment Regulations 2025 (SL 2025/43).
Schedule 2A: amended, on 31 October 2024, by regulation 5 of the Veterans’ Support Amendment Regulations (No 3) 2024 (SL 2024/213).
Schedule 2A: amended, on 27 June 2024, by regulation 5 of the Veterans’ Support Amendment Regulations (No 2) 2024 (SL 2024/91).
Schedule 2A: amended, on 9 May 2024, by regulation 5 of the Veterans’ Support Amendment Regulations 2024 (SL 2024/38).
Schedule 2A: amended, on 24 August 2023, by regulation 5 of the Veterans’ Support Amendment Regulations (No 2) 2023 (SL 2023/180).
Schedule 2A: amended, on 12 January 2023, by regulation 5 of the Veterans’ Support Amendment Regulations (No 4) 2022 (SL 2022/329).
Schedule 2A: amended, on 29 September 2022, by regulation 5 of the Veterans’ Support Amendment Regulations (No 3) 2022 (SL 2022/249).
Schedule 2A: amended, on 22 April 2022, by regulation 5 of Veterans’ Support Amendment Regulations (No 2) 2022 (SL 2022/80).
Schedule 2A: amended, on 20 January 2022, by regulation 5 of the Veterans’ Support Amendment Regulations (No 6) 2021 (SL 2021/437).
Schedule 2A: amended, on 14 October 2021, by regulation 5(1) of the Veterans’ Support Amendment Regulations (No 5) 2021 (LI 2021/260).
Schedule 2A: amended, on 14 October 2021, by regulation 5(2) of the Veterans’ Support Amendment Regulations (No 5) 2021 (LI 2021/260).
Schedule 2A: amended, on 5 August 2021, by regulation 5 of the Veterans’ Support Amendment Regulations (No 4) 2021 (LI 2021/181).
Schedule 2B Lump sum compensation for permanent impairment
Schedule 2B: inserted, on 7 December 2015, by regulation 13 of the Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251).
| Level of whole-person impairment (%) | Amount of lump sum compensation ($) | |
|---|---|---|
| 0 | 0.00 | |
| 1 | 0.00 | |
| 2 | 0.00 | |
| 3 | 0.00 | |
| 4 | 0.00 | |
| 5 | 2,500.00 | |
| 6 | 2,748.33 | |
| 7 | 3,021.33 | |
| 8 | 3,321.45 | |
| 9 | 3,651.37 | |
| 10 | 4,014.07 | |
| 11 | 4,555.16 | |
| 12 | 5,117.11 | |
| 13 | 5,696.76 | |
| 14 | 6,297.25 | |
| 15 | 6,920.23 | |
| 16 | 7,562.51 | |
| 17 | 8,228.84 | |
| 18 | 8,917.67 | |
| 19 | 9,632.14 | |
| 20 | 10,370.76 | |
| 21 | 11,135.02 | |
| 22 | 11,924.99 | |
| 23 | 12,743.86 | |
| 24 | 13,591.63 | |
| 25 | 14,468.32 | |
| 26 | 15,377.09 | |
| 27 | 16,316.40 | |
| 28 | 17,287.80 | |
| 29 | 18,294.50 | |
| 30 | 19,336.57 | |
| 31 | 20,413.93 | |
| 32 | 21,529.87 | |
| 33 | 22,684.32 | |
| 34 | 23,880.49 | |
| 35 | 25,116.80 | |
| 36 | 26,398.13 | |
| 37 | 27,722.77 | |
| 38 | 29,093.95 | |
| 39 | 30,514.93 | |
| 40 | 31,984.09 | |
| 41 | 33,504.64 | |
| 42 | 35,078.12 | |
| 43 | 36,707.83 | |
| 44 | 38,393.77 | |
| 45 | 40,139.05 | |
| 46 | 41,945.39 | |
| 47 | 43,814.34 | |
| 48 | 45,749.12 | |
| 49 | 47,751.37 | |
| 50 | 49,824.22 | |
| 51 | 51,969.34 | |
| 52 | 54,189.91 | |
| 53 | 56,487.58 | |
| 54 | 58,865.48 | |
| 55 | 61,326.94 | |
| 56 | 63,875.06 | |
| 57 | 66,511.49 | |
| 58 | 69,241.07 | |
| 59 | 72,065.39 | |
| 60 | 74,989.18 | |
| 61 | 78,015.84 | |
| 62 | 81,146.78 | |
| 63 | 84,388.56 | |
| 64 | 87,744.32 | |
| 65 | 91,215.66 | |
| 66 | 94,810.67 | |
| 67 | 98,529.34 | |
| 68 | 102,379.62 | |
| 69 | 106,364.75 | |
| 70 | 110,488.04 | |
| 71 | 114,757.39 | |
| 72 | 119,174.48 | |
| 73 | 123,747.26 | |
| 74 | 128,479.09 | |
| 75 | 133,377.85 | |
| 76 | 138,446.84 | |
| 77 | 143,694.01 | |
| 78 | 149,124.25 | |
| 79 | 154,745.52 | |
| 80 | 160,562.74 | |
| 81 | 166,584.00 | |
| 82 | 172,814.00 | |
| 83 | 179,260.00 | |
| 84 | 185,928.00 | |
| 85+ | 192,826.00 |
Schedule 3 Allowances and annuity payable under Part 1 of Schedule 1 of Act
[Revoked]Schedule 3: revoked, on 1 April 2017, by regulation 7 of the Veterans’ Support Amendment Regulations 2017 (LI 2017/37).
Michael Webster,
Clerk of the Executive Council.
Issued under the authority of the Legislation Act 2019.
Date of notification in Gazette: 4 December 2014.
Notes
1 General
This is a consolidation of the Veterans’ Support Regulations 2014 that incorporates the amendments made to the legislation so that it shows the law as at its stated date.
2 Legal status
A consolidation is taken to correctly state, as at its stated date, the law enacted or made by the legislation consolidated and by the amendments. This presumption applies unless the contrary is shown.
Section 78 of the Legislation Act 2019 provides that this consolidation, published as an electronic version, is an official version. A printed version of legislation that is produced directly from this official electronic version is also an official version.
3 Editorial and format changes
The Parliamentary Counsel Office makes editorial and format changes to consolidations using the powers under subpart 2 of Part 3 of the Legislation Act 2019. See also PCO editorial conventions for consolidations.
4 Amendments incorporated in this consolidation
Veterans’ Support Amendment Regulations (No 3) 2025 (SL 2025/217)
Veterans’ Support (Treatment Providers) Amendment Regulations 2025 (SL 2025/169)
Veterans’ Support Amendment Regulations (No 2) 2025 (SL 2025/124)
Veterans’ Support Amendment Regulations 2025 (SL 2025/43)
Veterans’ Support Amendment Regulations (No 3) 2024 (SL 2024/213)
Veterans’ Support Amendment Regulations (No 2) 2024 (SL 2024/91)
Veterans’ Support Amendment Regulations 2024 (SL 2024/38)
Veterans’ Support Amendment Regulations (No 2) 2023 (SL 2023/180)
Veterans’ Support Amendment Regulations 2023 (SL 2023/56)
Veterans’ Support Amendment Regulations (No 4) 2022 (SL 2022/329)
Veterans’ Support Amendment Regulations (No 3) 2022 (SL 2022/249)
Data and Statistics Act 2022 (2022 No 39): section 107(1)
Veterans’ Support Amendment Regulations (No 2) 2022 (SL 2022/80)
Veterans’ Support Amendment Regulations (No 6) 2021 (SL 2021/437)
Veterans’ Support Amendment Regulations (No 5) 2021 (LI 2021/260)
Veterans’ Support Amendment Regulations (No 4) 2021 (LI 2021/181)
Veterans’ Support Amendment Regulations (No 2) 2021 (LI 2021/27)
Veterans’ Support (Abatement) Amendment Regulations 2020 (LI 2020/27)
Veterans’ Support Amendment Regulations 2019 (LI 2019/44)
Social Security Act 2018 (2018 No 32): section 459
Veterans’ Support Amendment Regulations 2017 (LI 2017/37)
Veterans’ Support Amendment Regulations (No 3) 2015 (LI 2015/251)